Skip to Main Content
An official website of the United States government
Login Change: CDAS is now using the NIH Researcher Auth Service (RAS) to manage our existing login options. When logging into CDAS, you will be taken to RAS, where you can select your preferred login provider to access CDAS.

Browse Lab Results > 2014-0245

Trial Summary

About CDAS Project, PI, Publications: Validation of findings from the Epigenome-Wide Association Study of Breast Cancer

Datasets

Site: Breast

Inclusion Criteria:

  • Intervention Arm Females
  • No Rare Cancers
  • No Prior History of Any Cancer
  • T0 DNA Extracted from 2009-00553 or T0 Source Available
  • Pre-Exit T0 DNA Extracted from 2009-00553 or T0 Source Available
  • T0 Material is 4-7 Years Pre-Dx (Cases)
  • Source Material Available in T3/T4/T5
  • Pre-Exit Source Material Available in T3/T4/T5
  • T3-T5 Material is 1-3 Years Pre-Dx (Cases)

Matching Factors:

  • Age at Randomization (5 year intervals)
  • Study Year of Blood Draw
  • Calendar Year of Blood Draw
  • Material Type

Match Ratio: 1:1

Match Technique: Frequency matching only non-cases as controls.

Additional Matching Comments: Matching factors pertaining to blood draw apply to both time points.

Analytes:

  • C6orf79 percent methylated
  • ERCC1 percent methylated
  • MGAT4C percent methylated
  • OPTN percent methylated
  • PRKCDBP percent methylated
  • methylated C6orf79
  • methylated ERCC1
  • methylated MGAT4C
  • methylated OPTN
  • methylated PRKCDBP
  • unmethylated C6orf79
  • unmethylated ERCC1
  • unmethylated MGAT4C
  • unmethylated OPTN
  • unmethylated PRKCDBP

Number of Cases: 300

Number of Controls: 300